| |
NewswireToday - /newswire/ -
Santa Ana, CA, United States, 12/17/2008 - Cord blood banking is the once-in-a-lifetime opportunity for expectant parents to store stem cells found in their newborn’s umbilical cord blood.
|
| |
Cord blood stem cell transplants have been performed in more than 10,000 patients for more than 80 known diseases.
Cord blood banking continues to grow as a result of the increase in the awareness of the benefits of cord blood banking. An increase in cord blood research has resulted in more innovative cord blood banking services. Such an innovative cord blood banking service can be found in LifebankUSA®. LifebankUSA is the only cord blood banking company registered by the FDA (Food and Drug Administration) that offers Placenta-Cord banking, a cord blood banking service that enables expectant parents to store stem cells from both the placenta and the cord blood ─ two sources that help sustain a baby’s life during pregnancy. Placenta-Cord banking, like cord blood banking, is becoming increasingly popular among expectant parents.
Placenta-Cord banking can provide expectant parents with the most lifesaving stem cells possible by collecting not only the cord blood, but also an additional unit of stem cells from the placenta. And because banking stem cells from the placenta substantially increases the number of lifesaving stem cells available for transplant, which has been shown to improve overall treatment success and patient survival, thousands of families seeking greater peace of mind have chosen to bank stem cells from the placenta in addition to those found in the cord blood.
For additional information about Placenta-Cord banking and LifebankUSA, visit the cord blood banking company’s website at lifebankusa.com or call 1-877-543-3226.
About LifebankUSA
LifebankUSA is an AABB (formerly known as the American Association of Blood Banks) accredited and FDA (Food and Drug Administration) registered cord blood bank that has provided cord blood and placenta-derived stem cell banking services for tens of thousands of families around the world. LifebankUSA is the only company registered with the FDA to bank stem cells from both the placenta and the cord blood. Banking stem cells from both of these sources can enable expecting parents to store more lifesaving cells than they could with cord blood banking alone. Banking stem cells from the placenta significantly increases the number of stem cells available for transplant, which has been shown to improve treatment success and patient survival.
LifebankUSA is the world’s first cord blood bank to enable families to collect and preserve stem cells derived from the placenta as well as the umbilical cord (Placenta-Cord banking), which when transplanted can rebuild blood and the immune system, including red blood cells (which carry oxygen), white blood cells (immune cells that fight infections), and platelets (which clot blood and prevent hemorrhaging).
Additionally, the chance that a child will use his/her own stored stem cells during his/her lifetime is estimated at 1 in 400 (J.J. Nietfeld and F. Verter). These odds may increase if there is a family history of certain blood disorders or cancers. The potential risks and benefits of stem cell transplantation vary and depend on many factors, such as the amount and quality of the stem cells collected, the HLA compatibility between recipient and donor, and the client’s overall health. Talk with your health care provider.
|
